Which medication should be avoided in patients with soy and egg allergies?

Clevidipine is the medication that should be avoided in patients with soy and egg allergies. This is due to its formulation; clevidipine is an intravenous medication that is an lipid emulsion containing soy-derived phospholipids and egg yolk phospholipids. As such, individuals with allergies to soy or eggs may experience allergic reactions upon exposure to this medication.

In contrast, other medications listed, such as nicardipine, nifedipine, and verapamil, do not have components derived from soy or eggs in their formulations and thus are generally considered safer options for patients with those allergies. This distinction is critical for patient safety and helps guide appropriate medication management in those with known food allergies.